| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 1097 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=9 µg/ml |
| 1098 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=15.2 µg/ml |
| 1099 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=17.6 µg/ml |
| 1100 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=13.8 µg/ml |
| 1101 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=13 µg/ml |
| 1102 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=12.6 µg/ml |
| 1244 | 7849420 | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Cecropin B | 35 | IC50=30.6 µM |
| 1246 | 7849420 | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Cecropin B | 35 | IC50=32 µM |
| 1250 | 7849420 | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Cecropin B | 35 | IC50=34.5 |
| 1258 | 10951191 | GLFDIIKKIAESF | Aurein1.2 | 13 | LC50 = 10 µM |
| 1267 | 10951191 | GLFDIVKKVVGAFGSL | Aurein2.5 | 16 | LC50 = 10 µM |
| 1276 | 10951191 | GLFDIAKKVIGVIGSL | Aurein2.6 | 16 | LC50 = 10 µM |
| 1285 | 10951191 | GLFDIVKKIAGHIAGSI | Aurein 3.1 | 17 | LC50=10-100 µM |
| 1294 | 10951191 | GLFDIVKKIAGHIASSI | Aurein 3.2 | 17 | LC50 = 10 µM |
| 1303 | 10951191 | GLFDIVKKIAGHIVSSI | Aurein 3.3 | 17 | LC50 = 10 µM |
| 1712 | None | FLGWLFKWAKK | Gaegurin peptides SEQID NO: 1 | 11 | IC50 = 24.76 mM |
| 1718 | None | FLKWLFKWAKK | Gaegurin peptides SEQID NO: 2 | 11 | IC50 = 12.55 mM |
| 1724 | None | FLGWLFKWAWK | Gaegurin peptides SEQID NO: 3 | 11 | IC50 = 22.06 mM |
| 1730 | None | FLWWLFKWAWK | Gaegurin peptides SEQID NO: 4 | 11 | IC50 = 14.58 mM |
| 1748 | None | FLGWLFKWAKK | Gaegurin peptides SEQID NO: 1 | 11 | IC50 = 24.76 mM |
| 1756 | None | FLKWLFKWAKK | Gaegurin peptides SEQID NO: 2 | 11 | IC50 = 12.55 mM |
| 1764 | None | FLGWLFKWAWK | Gaegurin peptides SEQID NO: 3 | 11 | IC50 = 22.06 mM |
| 1772 | None | FLWWLFKWAWK | Gaegurin peptides SEQID NO: 4 | 11 | IC50 = 14.58 mM |
| 3158 | 23301519 | WRWRWRWRW | Cyclic [W(RW)4 ]-Dox | 9 | 51-74% inhibition of cell proliferation at 1 µM |
| 3162 | 23301519 | RWRWRWRW | linear (RW)4-Dox | 8 | 28-34% antiproliferative activity at 1 µM |
| 3232 | 22644847 | FLGWLFKWAWK | GA-W3 | 11 | IC50 =22.06 µM |
| 3239 | 22644847 | FLWWLFKWAWK | GA-W4 | 11 | IC50 =14.58 µM |
| 3246 | 22644847 | FLGWLFKWAKK | GA-K3 | 11 | IC50 |
| 3253 | 22644847 | FLKWLFKWAKK | GA-K4 | 11 | IC50 =12.55 µM |
| 3720 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50=17.05±6.61 µM |
| 3721 | 9815815 | fA*YwKA*T | Lan-7 | 7 | IC50= 16.93±1.84 µM |
| 3733 | 22644847 | FLGWLFKWAWK | GA-W3 | 11 | IC50= 22.06 µM |
| 3740 | 22644847 | FLWWLFKWAWK | GA-W4 | 11 | IC50= 14.58 µM |
| 3747 | 22644847 | FLKWLFKWAKK | GA-K3 | 11 | IC50= 24.76 µM |
| 3754 | 22644847 | FLKWLFKWAKK | GA-K4 | 11 | IC50= 12.55 µM |
| 4035 | 12631273, 9266696 | GLFDVIKKVASVIGGL | Citropin 1.1 | 16 | IC50= 5 M |
| 4044 | 12631273, 9266696 | glfdvikkvasviggl | Citropin 1.1D | 16 | IC50= 5 M |
| 4053 | 12631273, 9266696 | GLFAVIKKVASVIGGL | 3 | 16 | IC50= 6 M |
| 4062 | 12631273, 9266696 | GLFDVIKAVASVIGGL | 5 | 16 | IC50= 5 M |
| 4071 | 12631273, 9266696 | GLFDVIKKVAAVIGGL | 7 | 16 | IC50= 5 M |
| 4080 | 12631273, 9266696 | GLFDVIKKVASVIKGL | 11 | 16 | IC50= 5 M |
| 4089 | 12631273, 9266696 | GLFDVIKKVASVIKKL | 13 | 16 | IC50= 5 M |
| 4098 | 12631273, 9266696 | GLFDVIAKVASVIKKL | 14 | 16 | IC50= 5 M |
| 4107 | 12631273, 9266696 | GLFAVIKKVASVIKGL | 15 | 16 | IC50= 5 M |
| 4116 | 12631273, 9266696 | GLFAVIKKVASVIKKL | 16 | 16 | IC50= 5 M |
| 4125 | 12631273, 9266696 | GLFAVIKKVAAVIKKL | 17 | 16 | IC50= 5 M |
| 4134 | 12631273, 9266696 | GLFAVIKKVAAVIRRL | 18 | 16 | IC50= 5 M |
| 4143 | 12631273, 9266696 | GLFAVIKKVAKVIKKL | 19 | 16 | IC50= 5 M |
| 4152 | 12631273, 9266696 | GLFKVIKKVASVIGGL | 22 | 16 | IC50= 5 M |
| 4161 | 12631273, 9266696 | GLFKVIKKVAKVIKKL | 23 | 16 | IC50= 5 M |
| 4170 | 12631273, 9266696 | LGGIVSAVKKIVDFLG | retro | 16 | IC50= 5 M |
| 5005 | 24587350 | GIGKFLKKAKKFGKAFVKILKK | Pexiganan | 22 | LC50= 13 at 100 µM |
| 5006 | 24587350 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | LL 37 | 37 | LC50= 24 at 100 µM |